DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

MEDVi tirzepatide: November 2026 price and position

As of November 20, 2026, no current compounded tirzepatide price is shown for MEDVi: its page could not be read on November 20, 2026. This record shows no figure rather than an outdated one presented as current.

Released · Last reviewed · how we verify

Check MEDVi’s tirzepatide price ↗

Why no current price is shown

Its compounded prices did not render on November 20, 2026 (the page showed template placeholders). The August 2026 capture stays in the open dataset with its date. For programs that do print a tirzepatide price, see the tirzepatide price table.

FDA warning letters

FDA’s warning-letter index lists warning letter 721455 (dated February 20, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to MEDVi; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Limitations and what to check before you enroll

Compounded tirzepatide is not FDA-approved and is not the same product as Zepbound; it is made for an individual patient by a state-licensed pharmacy. Ask MEDVi for the all-in price at the maintenance dose, what is charged today and how often, and which pharmacy fills the prescription. A clinician decides whether any GLP-1 is right for you.

Frequently asked

How much does MEDVi charge for tirzepatide?

As of November 20, 2026, no current compounded tirzepatide price is shown for MEDVi: its page could not be read on November 20, 2026. This record shows no figure rather than an outdated one presented as current.

Is MEDVi’s tirzepatide FDA-approved?

No. Compounded tirzepatide from any telehealth program, MEDVi included, is not FDA-approved and is not the same product as Zepbound or Mounjaro. It is made for an individual patient by a state-licensed compounding pharmacy. Brand Zepbound is the FDA-approved version.

Where do these MEDVi figures come from?

From MEDVi’s own page (not readable Nov 20, November 20, 2026), converted to an all-in month-to-month figure (medication plus any required recurring fee, before tax). The source link and read date are listed below, and the same figures are in the open dataset.

MEDVi reviewMEDVi semaglutideTirzepatide price tableCheapest tirzepatide providersRankings

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.